Halozyme Therapeutics
HALO
$100.85
Share price
-0.48%
Change (1 day)
62.57%
Change (1 year)
Categories
Revenue for Halozyme Therapeutics (HALO)
Revenue in 2024 (TTM): A$1.54 Billion
According to Halozyme Therapeutics's latest financial reports the company's current revenue (TTM 
) is A$1.60 Billion. an increase over the revenue in the year 2023 that were of A$1.21 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Halozyme Therapeutics from 2002 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | A$1.63 B | 34.11% |
| 2023 | A$1.21 B | 25.48% |
| 2022 | A$0.97 B | 58.64% |
| 2021 | A$0.61 B | 75.71% |
| 2020 | A$0.34 B | 24.32% |
| 2019 | A$0.27 B | 29.86% |
| 2018 | A$0.21 B | -46.85% |
| 2017 | A$0.40 B | 99.28% |
| 2016 | A$0.20 B | 9.77% |
| 2015 | A$0.18 B | 101.4% |
| 2014 | A$92.05 M | 49.83% |
| 2013 | A$61.43 M | 50.84% |
| 2012 | A$40.72 M | -25.54% |
| 2011 | A$54.69 M | 307.83% |
| 2010 | A$13.41 M | -11.87% |
| 2009 | A$15.21 M | 22.51% |
| 2008 | A$12.42 M | 185.84% |
| 2007 | A$4.34 M | 248.96% |
| 2006 | A$1.24 M | |
| 2003 | A$0.02 M | -84.68% |
| 2002 | A$0.15 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | A$0.45 B | -71.88% | 🇺🇸 USA |
 | A$71.29 B | 4,336.29% | 🇺🇸 USA |
 | A$20.34 B | 1,166.20% | 🇺🇸 USA |
 | A$100.71 B | 6,166.57% | 🇺🇸 USA |
 | A$75.91 B | 4,623.65% | 🇫🇷 France |
 | A$140.59 B | 8,648.04% | 🇺🇸 USA |